← SynDRA

BMS-813160

SynDRA canonical compound SYN0040046 — structure-anchored drug synonym record

All known targets

• CCR2
• CCR5

Mechanisms of action (all sources)

• CCR2 ANTAGONIST
• C-C chemokine receptor type 2 antagonist
• CCR5 ANTAGONIST
• C-C chemokine receptor type 5 antagonist
• CC chemokine receptor antagonist
• CCR2 MODULATOR
• CCR5 MODULATOR

Cross-references

• PubChem CID: 51039119
• ChEMBL: CHEMBL4594419
• DrugBank: DB16240
• TTD: D0B1SG

Synonyms

• BMS-585059
• CCR2/CCR5 chemokine antagonist (immune disorders, cardiovascular disorders), BMS
• CCR2/CCR5 dual antagonist (cardiovascular disease), Bristol-Myers Squibb
• CCR2/CCR5 dual antagonist (immunology), Bristol-Myers Squibb
• RefChem:120744
• CCR2/CCR5 Antagonist BMS-813160
• BMS813160
• BMS 813160 - Bio-X
• MFCD31540731
• orb1302736
• SCHEMBL1554224
• EX-A2604
• BDBM50578294
• UNII-83U7957287
• BMS 813160 [WHO-DD]
• AKOS040758607
• AT32954
• BMS813160?
• AC-31373
• BB164193
• DA-61774
• MS-29009
• HY-109593
• CS-0033469
• T4584
• N-[(1R,2S,5R)-5-(tert-butylamino)-2-[(3S)-3-[(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-yl)amino]-2-oxopyrrolidin-1-yl]cyclohexyl]acetamide